LRRK2 and Parkinson disease: The existing literature on this topic is sparse; most reports addressing LRRK2 are limited in scope, while studies of GBA1 have largely concentrated on patients with Gaucher disease rather than PD cohorts carrying heterozygous pathogenic variants [32].